{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:10:07Z","timestamp":1795104607166,"version":"4.10.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZC20241828"],"award-info":[{"award-number":["GZC20241828"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M763416"],"award-info":[{"award-number":["2024M763416"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2024QB342"],"award-info":[{"award-number":["ZR2024QB342"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Laboratory Program","award":["SYS202205"],"award-info":[{"award-number":["SYS202205"]}]},{"name":"Dalian Key Medical Specialty Dengfeng Project","award":["2022ZZ210"],"award-info":[{"award-number":["2022ZZ210"]}]},{"name":"Liaoning Province Clinical Key Specialty Project","award":["2024SZ023"],"award-info":[{"award-number":["2024SZ023"]}]},{"name":"Key R&D Program of Shandong Province","award":["2024CXPT029"],"award-info":[{"award-number":["2024CXPT029"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32371283"],"award-info":[{"award-number":["32371283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taishan Scholars Program","award":["2023000027"],"award-info":[{"award-number":["2023000027"]}]},{"name":"Special Supporting Funds for Leading Talents at or Above the Provincial Level in Yantai City","award":["2023000090"],"award-info":[{"award-number":["2023000090"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03922-w","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T09:37:09Z","timestamp":1765532229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dual-targeted bacterial outer membrane vesicles enhance glioblastoma immunotherapy by regulating tumor microenvironment and inducing IFN-\u03b3-mediated ferroptosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pir Tariq","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"8","key":"3922_CR1","first-page":"1073","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, et al. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neurooncol. 2020;22(8):1073\u2013113.","journal-title":"Neurooncol"},{"issue":"7","key":"3922_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574\u201387.","journal-title":"JAMA"},{"issue":"16","key":"3922_CR3","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","volume":"185","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wissmann N, Botz M, Soyka SJ, Beretta CA, Pramatarov RL, Fankhauser L, Garofano L, Freudenberg A, Wagner J, Tanev DI, Ratliff M, Xie R, Kessler T, Hoffmann DC, Hai L, Dorflinger Y, Hoppe S, Yabo YA, Golebiewska A, Niclou SP, Sahm F, Lasorella A, Slowik M, Doring L, Iavarone A, Wick W, Kuner T, Winkler F. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell. 2022;185(16):2899\u2013917.","journal-title":"Cell"},{"issue":"4","key":"3922_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamaoncol.2019.6143","volume":"6","author":"AM Molinaro","year":"2020","unstructured":"Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, et al. Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol. 2020;6(4):495\u2013503 (Oberheim Bush, N. A).","journal-title":"JAMA Oncol"},{"issue":"1","key":"3922_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13046-021-02135-x","volume":"40","author":"R Vengoji","year":"2021","unstructured":"Vengoji R, Atri P, Macha MA, Seshacharyulu P, Perumal N, Mallya K, Liu Y, Smith LM, Rachagani S, Mahapatra S, Ponnusamy MP, Jain M, Batra SK, Shonka N. Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for glioblastoma. J Exp Clin Cancer Res. 2021;40(1):335.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"3922_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y Mei","year":"2023","unstructured":"Mei Y, Wang X, Zhang J, Liu D, He J, Huang C, Liao J, Wang Y, Feng Y, Li H, Liu X, Chen L, Yi W, Chen X, Bai HM, Wang X, Li Y, Wang L, Liang Z, Ren X, Qiu L, Hui Y, Zhang Q, Leng Q, Chen J, Jia G. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat Cancer. 2023;4(9):1273\u201391.","journal-title":"Nat Cancer"},{"issue":"683","key":"3922_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq3558","volume":"15","author":"F Yang","year":"2023","unstructured":"Yang F, Zhang D, Jiang H, Ye J, Zhang L, Bagley SJ, et al. Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy. Sci Transl Med. 2023;15(683):3558.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3922_CR8","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","volume":"14","author":"Y Chang","year":"2023","unstructured":"Chang Y, Cai X, Syahirah R, Yao Y, Xu Y, Jin G, Bhute VJ, Torregrosa-Allen S, Elzey BD, Won YY, Deng Q, Lian XL, Wang X, Eniola-Adefeso O, Bao X. CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. Nat Commun. 2023;14(1):2266.","journal-title":"Nat Commun"},{"issue":"16","key":"3922_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm8011","volume":"8","author":"Y Zou","year":"2022","unstructured":"Zou Y, Sun X, Yang Q, Zheng M, Shimoni O, Ruan W, et al. Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy. Sci Adv. 2022;8(16):8011.","journal-title":"Sci Adv"},{"issue":"1","key":"3922_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40280-3","volume":"14","author":"Y Zou","year":"2023","unstructured":"Zou Y, Sun Y, Wang Y, Zhang D, Yang H, Wang X, et al. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Nat Commun. 2023;14(1):4557.","journal-title":"Nat Commun"},{"issue":"11","key":"3922_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41551-022-00938-7","volume":"6","author":"Y Yao","year":"2022","unstructured":"Yao Y, Wang J, Liu Y, Qu Y, Wang K, Zhang Y, Chang Y, Yang Z, Wan J, Liu J, Nakashima H, Lawler SE, Chiocca EA, Cho CF, Bei F. Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood-brain barrier in rodents and primates. Nat Biomed Eng. 2022;6(11):1257\u201371.","journal-title":"Nat Biomed Eng"},{"key":"3922_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163446","author":"F Khan","year":"2023","unstructured":"Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI163446.","journal-title":"J Clin Invest"},{"issue":"19","key":"3922_CR13","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1016\/j.cell.2024.07.030","volume":"187","author":"DJ Kloosterman","year":"2024","unstructured":"Kloosterman DJ, Erbani J, Boon M, Farber M, Handgraaf SM, Ando-Kuri M, et al. Macrophage-mediated myelin recycling fuels brain cancer malignancy. Cell. 2024;187(19):5336\u201356.","journal-title":"Cell"},{"issue":"8","key":"3922_CR14","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ccell.2023.06.007","volume":"41","author":"HM Jeon","year":"2023","unstructured":"Jeon HM, Kim JY, Cho HJ, Lee WJ, Nguyen D, Kim SS, Oh YT, Kim HJ, Jung CW, Pinero G, Joshi T, Hambardzumyan D, Sakaguchi T, Hubert CG, McIntyre TM, Fine HA, Gladson CL, Wang B, Purow BW, Park JB, Park MJ, Nam DH, Lee J. Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling. Cancer Cell. 2023;41(8):1480\u201397.","journal-title":"Cancer Cell"},{"issue":"12","key":"3922_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202300061","volume":"3","author":"B Gong","year":"2023","unstructured":"Gong B, Jia W, Zhou Y, Xu Y, Wei Y, Gao H. Enhancing the treating efficacy of immunotherapy through the restructure of tumor microenvironment. Adv NanoBiomed Res. 2023;3(12):2300061.","journal-title":"Adv NanoBiomed Res"},{"issue":"6","key":"3922_CR16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","volume":"41","author":"JK Minami","year":"2023","unstructured":"Minami JK, Morrow D, Bayley NA, Fernandez EG, Salinas JJ, Tse C, Zhu H, Su B, Plawat R, Jones A, Sammarco A, Liau LM, Graeber TG, Williams KJ, Cloughesy TF, Dixon SJ, Bensinger SJ, Nathanson DA. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell. 2023;41(6):1048\u201360.","journal-title":"Cancer Cell"},{"issue":"7","key":"3922_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","volume":"24","author":"T Liu","year":"2022","unstructured":"Liu T, Zhu C, Chen X, Guan G, Zou C, Shen S, Wu J, Wang Y, Lin Z, Chen L, Cheng P, Cheng W, Wu A. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neuro Oncol. 2022;24(7):1113\u201325.","journal-title":"Neuro Oncol"},{"issue":"1","key":"3922_CR18","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s41467-023-37369-0","volume":"14","author":"WR Zhuang","year":"2023","unstructured":"Zhuang WR, Wang Y, Nie W, Lei Y, Liang C, He J, et al. Bacterial outer membrane vesicle based versatile nanosystem boosts the efferocytosis blockade triggered tumor-specific immunity. Nat Commun. 2023;14(1):1675.","journal-title":"Nat Commun"},{"issue":"12","key":"3922_CR19","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41565-024-01769-0","volume":"19","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Qin J, Yu D, Liu Y, Song D, Tian K, Chen H, Ye Q, Wang X, Xu T, Xuan H, Sun N, Ma W, Zhong J, Sun P, Song Y, Hu J, Zhao Y, Hou X, Meng X, Jiang C, Cai J. Polymer-locking fusogenic liposomes for glioblastoma-targeted SiRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol. 2024;19(12):1869\u201379.","journal-title":"Nat Nanotechnol"},{"issue":"29","key":"3922_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adma.202400502","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ma H, Li L, Sun C, Yu C, Wang L, et al. Dual-targeted novel temozolomide nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize glioblastoma to chemotherapy. Adv Mater. 2024;36(29):1\u201317.","journal-title":"Adv Mater"},{"issue":"2","key":"3922_CR21","doi-asserted-by":"publisher","first-page":"107518","DOI":"10.1016\/j.cclet.2022.05.032","volume":"34","author":"R Liu","year":"2023","unstructured":"Liu R, Luo C, Pang Z, Zhang J, Ruan S, Wu M, Wang L, Sun T, Li N, Han L, Shi J, Huang Y, Guo W, Peng S, Zhou W, Gao H. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chin Chem Lett. 2023;34(2):107518.","journal-title":"Chin Chem Lett"},{"issue":"40","key":"3922_CR22","doi-asserted-by":"publisher","first-page":"16377","DOI":"10.1021\/jacs.1c08521","volume":"143","author":"H Zhang","year":"2021","unstructured":"Zhang H, Han Y, Yang Y, Lin F, Li K, Kong L, Liu H, Dang Y, Lin J, Chen PR. Covalently engineered nanobody chimeras for targeted membrane protein degradation. J Am Chem Soc. 2021;143(40):16377\u201382.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"3922_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41467-017-00729-8","volume":"8","author":"OY Kim","year":"2017","unstructured":"Kim OY, Park HT, Dinh NTH, Choi SJ, Lee J, Kim JH, Lee SW, Gho YS. Bacterial outer membrane vesicles suppress tumor by interferon-gamma-mediated antitumor response. Nat Commun. 2017;8(1):626.","journal-title":"Nat Commun"},{"issue":"3","key":"3922_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41419-023-05738-8","volume":"14","author":"J Cai","year":"2023","unstructured":"Cai J, Ye Z, Hu Y, Ye L, Gao L, Wang Y, et al. Fatostatin induces ferroptosis through inhibition of the AKT\/mTORC1\/GPX4 signaling pathway in glioblastoma. Cell Death Dis. 2023;14(3):211.","journal-title":"Cell Death Dis"},{"issue":"23","key":"3922_CR25","doi-asserted-by":"publisher","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","volume":"17","author":"Z Cao","year":"2023","unstructured":"Cao Z, Liu X, Zhang W, Zhang K, Pan L, Zhu M, et al. Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma. ACS Nano. 2023;17(23):23746\u201360.","journal-title":"ACS Nano"},{"issue":"23","key":"3922_CR26","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-22-4001","volume":"83","author":"K Chang","year":"2023","unstructured":"Chang K, Chen Y, Zhang X, Zhang W, Xu N, Zeng B, et al. DPP9 stabilizes NRF2 to suppress ferroptosis and induce sorafenib resistance in clear cell renal cell carcinoma. Cancer Res. 2023;83(23):3940\u201355.","journal-title":"Cancer Res"},{"issue":"1","key":"3922_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52978-z","volume":"15","author":"V De Laat","year":"2024","unstructured":"De Laat V, Topal H, Spotbeen X, Talebi A, Dehairs J, Idkowiak J, et al. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nat Commun. 2024;15(1):8540.","journal-title":"Nat Commun"},{"issue":"3","key":"3922_CR28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1158\/2159-8290.CD-19-1500","volume":"11","author":"X Hong","year":"2021","unstructured":"Hong X, Roh W, Sullivan RJ, Wong KHK, Wittner BS, Guo H, et al. The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis. Cancer Discov. 2021;11(3):678\u201395.","journal-title":"Cancer Discov"},{"issue":"7755","key":"3922_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gijon M, Kennedy PD, Johnson JK, et al. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270\u20134.","journal-title":"Nature"},{"issue":"4","key":"3922_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8<Superscript>(+)<\/Superscript>T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365-378 e6.","journal-title":"Cancer Cell"},{"issue":"38","key":"3922_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adma.202301779","volume":"35","author":"J Pan","year":"2023","unstructured":"Pan J, Wang Z, Huang X, Xue J, Zhang S, Guo X, et al. Bacteria-derived outer-membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy. Adv Mater. 2023;35(38):1\u201312.","journal-title":"Adv Mater"},{"issue":"9","key":"3922_CR32","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1021\/acs.nanolett.8b01805","volume":"18","author":"Y Tian","year":"2018","unstructured":"Tian Y, Zhou M, Shi H, Gao S, Xie G, Zhu M, et al. Integration of cell-penetrating peptides with rod-like bionanoparticles: virus-inspired gene-silencing technology. Nano Lett. 2018;18(9):5453\u201360.","journal-title":"Nano Lett"},{"issue":"13","key":"3922_CR33","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.7150\/thno.25608","volume":"8","author":"H Hu","year":"2018","unstructured":"Hu H, Wang J, Wang H, Tan T, Li J, Wang Z, Sun K, Li Y, Zhang Z. Cell-penetrating peptide-based nanovehicles potentiate lymph metastasis targeting and deep penetration for anti-metastasis therapy. Theranostics. 2018;8(13):3597\u2013610.","journal-title":"Theranostics"},{"issue":"2","key":"3922_CR34","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1021\/acsnano.4c16128","volume":"19","author":"JH Lee","year":"2025","unstructured":"Lee JH, Yang SB, Park SJ, Kweon S, Ma G, Seo M, et al. Cell-Penetrating peptide like anti-Programmed cell Death-Ligand 1 peptide conjugate-based self-assembled nanoparticles for immunogenic photodynamic therapy. ACS Nano. 2025;19(2):2870\u201389.","journal-title":"ACS Nano"},{"issue":"30","key":"3922_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403460121","volume":"121","author":"S Tang","year":"2024","unstructured":"Tang S, Tang D, Zhou H, Li Y, Zhou D, Peng X, et al. Bacterial outer membrane vesicle nanorobot. Proc Natl Acad Sci USA. 2024;121(30):e2403460121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3922_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1172\/JCI169251","volume":"134","author":"Y Choi","year":"2024","unstructured":"Choi Y, Saron WA, O\u2019Neill A, Senanayake M, Wilder-Smith A, Rathore AP. St John, A. L., NKT cells promote Th1 immune bias to dengue virus that governs long-term protective antibody dynamics. J Clin Invest. 2024;134:18.","journal-title":"J Clin Invest"},{"issue":"6","key":"3922_CR37","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","volume":"169","author":"AE Overacre-Delgoffe","year":"2017","unstructured":"Overacre-Delgoffe AE, Chikina M, Dadey RE, Yano H, Brunazzi EA, Shayan G, et al. Interferon-gamma drives T(reg) fragility to promote anti-tumor immunity. Cell. 2017;169(6):1130-1141 e11.","journal-title":"Cell"},{"issue":"1","key":"3922_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03922-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03922-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03922-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T18:38:27Z","timestamp":1768847907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03922-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3922"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03922-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS) (No. SYXK-2020-0042). The acquisition of human tissue samples was approved by the Ethics Review Committee of the Central Hospital of Dalian University of Technology (No. YN2024-022-03). Written informed consent was obtained from all participants. All procedures involving human participants were conducted in accordance with the Declaration of Helsinki. All human data were de-identified prior to analysis to protect participant privacy and personally identifiable information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}